Showing results (161-170 of 198) with videos related to

Sort By:
Pageof 20
Antiviral Research|July 12, 2023
Evaluating Z-FA-FMK, a host cathepsin L protease inhibitor, as a potent and broad-spectrum antiviral therapy against SARS-CoV-2 and related coronavirusesJu Hwan Jeong, Jang-Hoon Choi, Beom Kyu Kim, et al.
Journal of Medical Virology|June 10, 2003
Genetic and antigenic characterization of measles viruses that circulated in Korea during the 2000-2001 epidemicByoung-Kuk Na, Ju-Mi Shin, Joo-Yeon Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2021
Longitudinal Analysis of Memory T-Cell Responses in Survivors of Middle East Respiratory SyndromeHyoung Shik Shin, Yeonjae Kim, Jihye Kang, et al.
Emerging Microbes & Infections|December 9, 2020
An infectious cDNA clone of a growth attenuated Korean isolate of MERS coronavirus KNIH002 in clade BMinwoo Kim, Hee Cho, Seung-Hoon Lee, et al.
Molecular Phylogenetics and Evolution|November 7, 2018
Distinct molecular evolution of influenza H3N2 strains in the 2016/17 season and its implications for vaccine effectivenessJin Il Kim, Sehee Park, Hyuk Chu, et al.
Scientific Reports|October 17, 2018
BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impactsJoo-Yeon Lee, Jisun Kim, Sung-Won Kim, et al.
Journal of Medical Virology|May 13, 2026
Broad Neutralizing Activity of Monoclonal Antibodies Against the Omicron Variants Isolated From Patients With Early Severe Acute Respiratory Syndrome Coronavirus-2Da Sol Kim, Uijin Kim, Hye-Min Woo, et al.
JCI Insight|December 27, 2019
Genetic and pathogenic diversity of severe fever with thrombocytopenia syndrome virus (SFTSV) in South KoreaSeok-Min Yun, Su-Jin Park, Young-Il Kim, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 7, 2016
Coronary artery calcification in Korean patients with incident dialysisEunjin Bae, Eun Yong Seong, Byoung-Geun Han, et al.
JAMA Internal Medicine|October 25, 2016
Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service MedicareCunlin Wang, Robert Kane, Mark Levenson, et al.
Pageof 20